Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial
National Natural Science Foundation of China; Science and Technology Program of Guangdong Province; National Key Research and Development Program of China.
Authors
- Li Xuan (ORCID: https://orcid.org/0000-0002-6176-7411)
- Zhongli Hu
- Ren Lin (ORCID: https://orcid.org/0000-0002-9402-0883)
- Qifa Liu (ORCID: https://orcid.org/0000-0003-4015-3952)
- Fen Huang (ORCID: https://orcid.org/0000-0001-5064-2528)
- He Hai
- Zhiping Fan (ORCID: https://orcid.org/0000-0002-3652-3618)
- Zhangkun Li
- Guopan Yu (ORCID: https://orcid.org/0000-0002-5732-0318)
- Xiaojun Xu (ORCID: https://orcid.org/0000-0003-1388-2535)
- Pengcheng Shi (ORCID: https://orcid.org/0000-0002-5626-3366)
- Yu Wang
- Na Xu
- Jing Sun (ORCID: https://orcid.org/0000-0002-5130-4835)
- Ping Zhu (ORCID: https://orcid.org/0000-0001-6263-7507)
- Hua Jin
- Ruijuan Sun
- Yu Zhang
- Yirong Jiang
- Yunxin Zeng
Institutions
- Sun Yat-sen University (CN)
- Peking University (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Nanfang Hospital (CN)
- Dongguan People’s Hospital (CN)
- Peking University People's Hospital (CN)
- Chenzhou First People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- The Lancet Regional Health - Western Pacific
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1016/j.lanwpc.2025.101664
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77